Immunome, Inc. ("Immunome") , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public offering ...

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

Investing.com -- Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares starting to trade at $16.12. The company priced 8,750,000 ...

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) reached a new 52-week high during trading on Thursday after Needham & Company LLC raised their price target on the stock from $44.00 to $51.00. Needham & ...

New York-area Knicks and Rangers fans who have been blacked out of games this month on the Optimum cable TV network can ...

Craig-Hallum analyst Eric Stine maintained a Buy rating on Enphase Energy (ENPH – Research Report) today. The company’s shares closed yesterday ...

And the rest of the league is struggling to keep up. Yankees owner Hal Steinbrenner, whose individual net worth is $1.5 billion, admitted that even the Yankees, by far the most successful franchise in ...